Alithea Genomics

Business Model
B2B
Total Funding
$7.2M
Last Round
$3.7M SeedMar 2026
Rounds
2

About

Alithea Genomics delivers high-throughput transcriptomics kits and services for scalable RNA-seq, gene expression profiling, and compound screening. The company develops solutions that streamline the generation of big RNA data, including MERCURIUS DRUG-seq, FLASH-seq, and BRB-seq kits used for industrial-scale screening, toxicology, and target validation. Its offerings cover extraction-free workflows from cells, spheroids, blood, and plant samples for research and pharmaceutical customers.

Summary

Alithea Genomics is a Biotech company. It has raised $7.2M in total across 2 rounds, most recently a $3.7M Seed round in Mar 2026. Investors include Zürcher Kantonalbank and TechU Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedMar 2026
$3.7M

Sign up to see all 2 rounds

Extension Round through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alithea Genomics on Indexed.vc
<a href="https://indexed.vc/companies/alithea-genomics"><img src="https://indexed.vc/api/badge/company/alithea-genomics" alt="Alithea Genomics on Indexed.vc" width="260" height="76" /></a>